Compare Jones Lang LaSalle Inc (JLL) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs Johnson & Johnson — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while Johnson & Johnson trades at $250.66 (market cap $598.96B). The key difference: Johnson & Johnson is far larger — about 39.6× Jones Lang LaSalle Inc's market cap, and Johnson & Johnson pays a 2.15% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| JLL | JNJ | |
|---|---|---|
Market Cap | $15.12B | $598.96B |
Sector | Real Estate | Health |
52-Week High | $358.66 | $267.24 |
52-Week Low | $253.48 | $164.36 |
Enterprise Value | $18.66B | $631.90B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.15% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
